News Breaks |
|
|
| September 6, 2012 |
| 04:55 EDT |  | MDT, MDT, JNJ, JNJ, STJ, STJ, ABT, ABT, BAYRY, BAYRY | Opal Financial Group to host a summit
Medical Devices Summit is being held in Minneapolis on September 6-7. |
|
|
News For MDT;JNJ;STJ;ABT;BAYRY From The Last 14 Days Check below for free stories on MDT;JNJ;STJ;ABT;BAYRY the last two weeks. |
|
|
| May 23, 2013 |
| 10:08 EDT |  | JNJ | On The Fly: Analyst Initiation Summary
 Subscribe for More Information |
|
| 07:31 EDT |  | JNJ | Janssen expects to have more than 25 brand line extensions by 2017
Subscribe for More Information |
|
| 06:29 EDT | | JNJ | Johnson & Johnson coverage assumed with an Underperform at Credit Suisse
Subscribe for More Information |
|
| 06:05 EDT | | BAYRY | Bayer initiated with an Equal Weight at Morgan Stanley
|
|
| 05:44 EDT | | STJ | St. Jude Medical study of EnligHTN shows sustained blood pressure reduction
St. Jude Medical announced that the company's EnligHTN Multi-Electrode Renal Denervation System provides a safe, rapid and sustained reduction in blood pressure measurements after one year. Patients enrolled in the EnligHTN I trial had an average blood pressure of 176 / 96 mmHg and patients were drug-resistant, meaning their blood pressure could not be controlled through medication. At one year, patients treated with the EnligHTN Renal Denervation System experienced an average systolic blood pressure reduction of 27 mmHg points when measured in an office setting. |
|
| 05:40 EDT | | MDT | Medtronic CoreValue system gains CE mark for transcatheter VIV procedures
Subscribe for More Information |
|
| 05:38 EDT | | MDT | Medtronic's In.Pact Falcon yields positive outcomes in small coronary arteries
Subscribe for More Information |
|
| May 22, 2013 |
| 16:00 EDT |  | JNJ | Options Update; May 22, 2013
Subscribe for More Information |
|
| 07:48 EDT | | MDT | FDA Orthopaedic and Rehabilitation Devices Panel to hold a meeting
Subscribe for More Information |
|
| 07:28 EDT | | ABT | UBS to host a conference
Global Healthcare Services Conference is being held in New York on May 20-22 with webcasted company presentations to begin on May 22 at 8 am; not all company presentations may be webcasted. Webcast Link |
| |
| May 21, 2013 |
| 13:02 EDT | | MDT | Medtronic announces CE Mark for CapSureFix Novus
Medtronic announced CE Mark and launch of its CapSureFix Novus 5076 Lead, which is now approved in the EU for use in an MRI environment when paired with a Medtronic MR-Conditional pacemaker. The lead has not been approved for that use in the U.S. |
|
| 11:38 EDT | | MDT | High option volume stocks: KOS MWE HGG SOL MDT
|
|
| 09:25 EDT | | MDT | On The Fly: Pre-market Movers
Subscribe for More Information |
|
| 08:03 EDT | | ABT | Abbott announces CE Mark for coronary drug eluting stent
Subscribe for More Information |
|
| 07:24 EDT | | JNJ | Global Health Care to host a conference
Subscribe for More Information |
|
| 07:19 EDT |  | MDT | Medtronic sees FY14 EPS $3.80-$3.85, consensus $3.84
Sees FY14 revenue growth up 3%-4% on a constant currency basis. |
|
| 07:17 EDT | | MDT | Medtronic reports Q4 EPS $1.10, consensus $1.03
Subscribe for More Information |
|
| 05:54 EDT | | MDT | Medtronic announces primary results from Global Symplicity Registry
Subscribe for More Information |
|
| 05:51 EDT | | MDT | Medtronic CoreValue ADVANCE study shows low mortality rates
Subscribe for More Information |
|
| May 20, 2013 |
| 17:20 EDT | | BAYRY | Regeneron,, Bayer, Genentech resolve certain patent disputes
Subscribe for More Information |
| |
|
|
|
|
